Cite
HARVARD Citation
Procopio, G. et al. (n.d.). 880PSubgroups analysis and circulating biomarkers evaluation of RESORT trial: A randomized phase II study in metastatic renal cell carcinoma (mRCC) patients (pts) to evaluate the efficacy of sorafenib after metastasectomy. Annals of oncology. p. . [Online].